Home › Funds › Logos Global Management LP › TRVI

Logos Global Management LP position in TRVI

TREVI THERAPEUTICS INC · Health Care

Logos Global Management LP reported holding 1,880,000 shares of TRVI (TREVI THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$35.1M, representing 1.51% of its reported portfolio and ranking #21 among its reported holdings. Logos Global Management LP has disclosed TRVI holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)1.88M sh
Reported value held$35.06M
Portfolio Weight1.51%
First reportedQ1 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Logos Global Management LP's TRVI position evolved

Logos Global Management LP first disclosed a stake in TRVI in Q1 2024 at 2,200,000 shares (US$7.6M). The position peaked in Q2 2026 at 1,880,000 shares, worth US$35.1M. Across 10 filings, Logos Global Management LP increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,880,000 shares valued at US$35.1M — a reduction of -520,000 shares quarter over quarter.. Notable position changes include a 66% trim in Q1 2025 (shares fell 13% over the following quarter), a 100% increase in Q2 2025 (shares rose 67% over the following quarter), a 159% increase in Q3 2025 (shares rose 37% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 2.20M $7.59M New
Q2 2024 2.80M $8.34M Add
Q3 2024 2.75M $9.19M Reduce
Q4 2024 1.25M $5.15M Reduce
Q1 2025 424.71K $2.67M Reduce
Q2 2025 850.00K $4.65M Add
Q3 2025 2.20M $20.13M Add
Q4 2025 1.55M $19.41M Reduce
Q1 2026 2.40M $28.63M Add
Q2 2026 1.88M $35.06M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TRVI and 13F data

TRVI (TREVI THERAPEUTICS INC) is a Health Care company. 64 other funds we track also report a position in TRVI — the largest reported positions include NEA Management Company, LLC (US$246.6M), Frazier Life Sciences Management, L.P. (US$185.4M), Vivo Capital, LLC (US$95.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TRVI

All TRVI fund holders →

FAQ

How long has Logos Global Management LP held TRVI?

Logos Global Management LP has disclosed TRVI holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is Logos Global Management LP's current position in TRVI?

As of Q2 2026, Logos Global Management LP holds 1.88M shares of TRVI (TREVI THERAPEUTICS INC), valued at $35.06M, representing 1.51% of its reported portfolio and ranking #21.

Has Logos Global Management LP been buying or selling TRVI?

In the latest 13F filing (Q2 2026), Logos Global Management LP reduced its position in TRVI. The position peaked in Q2 2026 at 1.88M shares.

Which other funds hold TRVI?

Other major institutional holders of TRVI include NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Vivo Capital, LLC, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.